Advanced Health Intelligence (Advanced Health Intelligence) Forward Dividend Yield % : 0.00% (As of Jun. 02, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Advanced Health Intelligence Forward Dividend Yield %?

As of today (2024-06-02), the Forward Annual Dividend Yield of Advanced Health Intelligence is 0.00%.

As of today (2024-06-02), the Trailing Annual Dividend Yield of Advanced Health Intelligence is 0.00%.

AHI's Forward Dividend Yield % is not ranked ^*
in the Software industry.
Industry Median: 2.05
* Ranked among companies with meaningful Forward Dividend Yield % only.

Advanced Health Intelligence's Dividends per Share for the three months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Advanced Health Intelligence's Forward Dividend Yield %

For the Software - Application subindustry, Advanced Health Intelligence's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Health Intelligence's Forward Dividend Yield % Distribution in the Software Industry

For the Software industry and Technology sector, Advanced Health Intelligence's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Advanced Health Intelligence's Forward Dividend Yield % falls into.

Advanced Health Intelligence Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Advanced Health Intelligence (NAS:AHI) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Advanced Health Intelligence Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Advanced Health Intelligence's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Health Intelligence (Advanced Health Intelligence) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Advanced Health Intelligence Ltd (NAS:AHI) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

MYZQF:USA AHI:Australia

Address

71-73 The Esplanade, Unit 5, South Perth, Perth, WA, AUS, 6151

Website

https://www.ahi.tech

Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.